Current clinical trials for the proteasome inhibitor PS-341

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2000年 / 14卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1589 / +
页数：5
相关论文
共 50 条
  • [41] The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells
    Matta, H
    Chaudhary, PM
    [J]. CANCER BIOLOGY & THERAPY, 2005, 4 (01) : 77 - 82
  • [42] The proteasome inhibitor PS-341 induces Cox-2 in murine and human endothelial cells.
    Csizmadia, V
    Rottman, J
    Bouchard, P
    Raczynski, A
    Juedes, M
    White, P
    Sasseville, V
    [J]. TOXICOLOGICAL SCIENCES, 2003, 72 : 47 - 47
  • [43] Proteasome inhibitor PS-341 sensitizes drug-refractory human transitional cell tumors to gemcitabine
    Kamat, AM
    Karashima, T
    Davis, D
    Dinney, C
    McConkey, DJ
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 128 - 128
  • [44] Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)
    Yin, D
    Zhou, H
    Kumagai, T
    Liu, GT
    Ong, JM
    Black, KL
    Koeffler, HP
    [J]. ONCOGENE, 2005, 24 (03) : 344 - 354
  • [45] The proteasome inhibitor PS-341 inhibits metastases in a Lewis lung carcinoma model by cytotoxicity and antiangiogenesis.
    Lin, J
    Pien, C
    Pink, M
    Adams, J
    Elliott, P
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3667S - 3667S
  • [46] Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)
    Dong Yin
    Hong Zhou
    Takashi Kumagai
    Gentao Liu
    John M Ong
    Keith L Black
    H Phillip Koeffler
    [J]. Oncogene, 2005, 24 : 344 - 354
  • [47] The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents
    Ma, MH
    Yang, HH
    Parker, K
    Manyak, S
    Friedman, JM
    Altamirano, C
    Wu, ZQ
    Borad, MJ
    Frantzen, M
    Roussos, E
    Neeser, J
    Mikail, A
    Adams, J
    Sjak-Shie, N
    Vescio, RA
    Berenson, JR
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (03) : 1136 - 1144
  • [48] Proteasome inhibitor PS-341 inhibits human multiple myeloma cell growth in a murine model.
    LeBlanc, R
    Catley, L
    Hideshima, T
    Pien, CS
    Elliott, PJ
    Anderson, KC
    [J]. BLOOD, 2001, 98 (11) : 774A - 774A
  • [49] Blockade of Hsp27 overcomes bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells
    Chauhan, D
    Li, GL
    Shringarpure, R
    Podar, K
    Ohtake, Y
    Hideshima, T
    Anderson, KC
    [J]. CANCER RESEARCH, 2003, 63 (19) : 6174 - 6177
  • [50] Anti-tumor activity of the proteasome inhibitor PS-341 in mantle cell lymphoma B cells.
    Pham, L
    Tamayo, A
    Lo, P
    Yoshimura, L
    Ford, RJ
    [J]. BLOOD, 2001, 98 (11) : 465A - 465A
12345